Stay updated on Orally Administered AG-120 in Hematologic Malignancies Clinical Trial
Sign up to get notified when there's something new on the Orally Administered AG-120 in Hematologic Malignancies Clinical Trial page.

Latest updates to the Orally Administered AG-120 in Hematologic Malignancies Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.4.2 was added and Revision: v3.4.1 was removed, reflecting the latest site release.SummaryDifference0.1%

- Check12 days agoChange DetectedOnly the site revision line changed: the history shows removal of Revision: v3.4.0 and addition of Revision: v3.4.1, indicating a background update rather than modifications to study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedNew UI shows color-coded diffs (green for additions, red for deletions) and adds a glossary toggle, plus minor wording and revision-label changes (e.g., No FEAR Act data capitalization, Revision: v3.4.0) that do not affect study content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check33 days agoChange DetectedThe Record History shows a new revision entry (v3.3.4) replacing the prior v3.3.3. This is a minor administrative update with no changes to study data or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check55 days agoChange DetectedAddition of Revision: v3.3.3 to the page history; removal of HHS Vulnerability Disclosure and Revision: v3.3.2 from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange DetectedRevision: v3.3.2 replaces Revision: v3.2.0 on the page.SummaryDifference0.1%

Stay in the know with updates to Orally Administered AG-120 in Hematologic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Orally Administered AG-120 in Hematologic Malignancies Clinical Trial page.